Assessment of Mediastinal Masses With Diffusion Weighted MR Imaging
NCT03214341 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 24
Last updated 2017-07-11
Summary
Differentiation between benign and malignant mediastinal tumors as well as characterization and grading of malignancy which is essential for treatment planning as well as for prognosis
Conditions
- Mediastinal Tumor
Interventions
- RADIATION
-
MRI diffusion
using MRI diffusion to differentiate between benign and malignant mediastinal masses
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Mostafa Thabet Hussein, professor · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-12-01
- Primary Completion
- 2019-12-01
- Completion
- 2019-12-30
Countries
- Egypt
Study Locations
More Related Trials
-
Metabolic Insights: the Impact of F-18 FDG PET/CT in Adult Lymphoma
NCT06737835 ·Status: NOT_YET_RECRUITING
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
Study on the Value of Non-invasive Dual-Pet Information in Subtype of Metastatic Breast Cancer
NCT04758416 ·Status: UNKNOWN
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
Monitoring of Breast Cancers Treated by Neoadjuvant Therapy Via Diffusion-weighted Magnetic Resonance Imaging
NCT02798484 ·Status: COMPLETED ·Phase: NA
-
Early Prediction of Neoadjuvant Chemotherapy Response in Bladder Cancer Using Quantitative Multiparametric MRI
NCT07202845 ·Status: RECRUITING
-
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
NCT06350526 ·Status: COMPLETED
-
Monitoring Response to Neoadjuvant Chemotherapy in Breast Cancer Using Ultrafast DCE-MRI
NCT05744518 ·Status: UNKNOWN
-
Wholebody MRI In Lung Cancer StagiNg
NCT02716051 ·Status: COMPLETED ·Phase: NA
-
PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)
NCT03244566 ·Status: COMPLETED
-
MR/PET in the Evaluation of Patients With Esophageal Cancer
NCT02547610 ·Status: UNKNOWN
-
The Role of 18F-FDG-PET/CT Scan in Lung Cancer Patients
NCT04395651 ·Status: UNKNOWN
-
SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification
NCT04803331 ·Status: UNKNOWN ·Phase: NA
-
Role of Positron Emission Tomography/ Computed Tomography (PET/CT) and in Bone Metastases.
NCT04080271 ·Status: COMPLETED
-
Detection and Characterization of Residual Masses in Lymphomas
NCT02300402 ·Status: COMPLETED
-
The Value of Diffusion-weighted Imaging in Evaluating the Early Efficacy of Liver Metastasis in Colorectal Cancer
NCT03088163 ·Status: UNKNOWN ·Phase: NA
-
Magnetic Resonance Imaging of the Whole Body, Including Diffusion, in the Medical Evaluation of Breast Cancers at High Risk for Metastasis and the Follow-up of Metastatic Cancers
NCT02966574 ·Status: UNKNOWN ·Phase: NA
-
Detection of Bone Marrow Metastases With Magnetic Resonance Imaging
NCT03876392 ·Status: UNKNOWN ·Phase: NA
-
PET/MR in Surgical Planning for Breast CA Treated With Neoadj Chemo
NCT04149353 ·Status: TERMINATED ·Phase: NA
-
Whole-body MR in Staging Bone and Soft Tissue Metastases in Breast Cancer Patients(MetaMaRBo)
NCT01291082 ·Status: UNKNOWN
-
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
NCT00592462 ·Status: COMPLETED
-
Clinical Application of 99mTc-FDPH46 SPECT/CT Imaging in Malignant Solid Tumor: a Prospective Exploratory Study
NCT06753513 ·Status: NOT_YET_RECRUITING
-
Molecular Evaluation in Metastatic Breast Cancer
NCT03358589 ·Status: UNKNOWN ·Phase: NA
-
Molecular and Whole-body MR Imaging in Lymphomas
NCT02389101 ·Status: COMPLETED ·Phase: NA
-
Multi-parametric MRI and Dual-energy CT in Patients of Gastric Cancer
NCT05508126 ·Status: RECRUITING